生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | NDMC101 effectively suppresses osteoclastogenesis by reducing osteoclast differentiation through the downregulation of NFATc1-mediated gene expression. It mimics the DPP4 substrate, significantly hindering early T-cell activation by inhibiting DPP4. NDMC101 is suitable for researching bone conditions, including rheumatoid arthritis and synovial inflammation, among others[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.76mL 0.75mL 0.38mL |
18.82mL 3.76mL 1.88mL |
37.64mL 7.53mL 3.76mL |
参考文献 |
---|